4.6 Review

Will Artificial Intelligence for Drug Discovery Impact Clinical Pharmacology?

Journal

CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 107, Issue 4, Pages 780-785

Publisher

WILEY
DOI: 10.1002/cpt.1795

Keywords

-

Funding

  1. National Institutes of Health (NIH) [P30 CA118100, U24 CA224370, U01 CA239108, U24 TR002278]

Ask authors/readers for more resources

As the field of artificial intelligence and machine learning (AI/ML) for drug discovery is rapidly advancing, we address the question What is the impact of recent AI/ML trends in the area of Clinical Pharmacology? We address difficulties and AI/ML developments for target identification, their use in generative chemistry for small molecule drug discovery, and the potential role of AI/ML in clinical trial outcome evaluation. We briefly discuss current trends in the use of AI/ML in health care and the impact of AI/ML context of the daily practice of clinical pharmacologists.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available